Megakaryocyte–erythroid progenitor cell

Platelets_release_in_mature_megakaryocytes_.gif

Megakaryocyte–erythroid progenitor cell

Megakaryocyte–erythroid progenitor cell (MEP) is a type of hematopoietic progenitor cell that gives rise to both megakaryocytes and erythrocytes. These progenitor cells are crucial in the process of hematopoiesis, which is the formation of blood cellular components.

Development and Differentiation

MEPs originate from hematopoietic stem cells (HSCs) in the bone marrow. HSCs differentiate into common myeloid progenitor (CMP) cells, which further differentiate into MEPs. The differentiation pathway of MEPs can lead to the formation of either megakaryocytes, which are responsible for the production of platelets, or erythrocytes, which are red blood cells responsible for oxygen transport.

Megakaryocyte Lineage

When MEPs differentiate into megakaryocytes, they undergo a process called endomitosis, where the cell replicates its DNA without cell division, leading to a large cell with multiple copies of DNA. These megakaryocytes then fragment into platelets, which play a critical role in hemostasis and thrombosis.

Erythroid Lineage

Alternatively, MEPs can differentiate into erythroid progenitor cells, which further mature into erythroblasts and eventually into erythrocytes. This process is regulated by the hormone erythropoietin, which is produced by the kidneys in response to low oxygen levels in the blood.

Regulation

The differentiation of MEPs is tightly regulated by various cytokines and transcription factors. Key transcription factors involved include GATA1, FOG1, and RUNX1. These factors help determine whether the MEP will follow the megakaryocyte or erythroid lineage.

Clinical Significance

Abnormalities in the differentiation of MEPs can lead to various hematological disorders. For instance, impaired differentiation into erythrocytes can result in anemia, while issues in megakaryocyte differentiation can lead to disorders such as thrombocytopenia or myeloproliferative neoplasms.

Research and Applications

Understanding the mechanisms of MEP differentiation has significant implications for regenerative medicine and stem cell therapy. Research in this area could lead to new treatments for blood disorders and improve the outcomes of bone marrow transplants.

See Also

• Hematopoiesis
• Hematopoietic stem cell
• Common myeloid progenitor
• Megakaryocyte
• Erythrocyte
• Platelet
• Erythropoiesis

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian